- •Preface
- •Contributors
- •Dedication
- •INFECTIOUS DISEASES
- •ACINETOBACTER
- •BACILLUS SPECIES INFECTIONS
- •ESCHERICHIA COLI
- •GONOCOCCAL OCULAR DISEASE
- •INFECTIOUS MONONUCLEOSIS
- •MICROSPORIDIAL INFECTION
- •MOLLUSCUM CONTAGIOSUM
- •MORAXELLA
- •PROPIONIBACTERIUM ACNES
- •PROTEUS
- •PSEUDOMONAS AERUGINOSA
- •STREPTOCOCCUS
- •VARICELLA AND HERPES ZOSTER
- •PARASITIC DISEASES
- •PEDICULOSIS AND PHTHIRIASIS
- •NUTRITIONAL DISORDERS
- •INFLAMMATORY BOWEL DISEASE
- •DISORDERS OF CARBOHYDRATE METABOLISM
- •MUCOPOLYSACCHARIDOSIS IH
- •MUCOPOLYSACCHARIDOSIS IH/S
- •MUCOPOLYSACCHARIDOSIS II
- •MUCOPOLYSACCHARIDOSIS III
- •MUCOPOLYSACCHARIDOSIS IV
- •MUCOPOLYSACCHARIDOSIS VI
- •MUCOPOLYSACCHARIDOSIS VII
- •DISORDERS OF LIPID METABOLISM
- •HEMATOLOGIC AND CARDIOVASCULAR DISORDERS
- •CAROTID CAVERNOUS FISTULA
- •DERMATOLOGIC DISORDERS
- •ERYTHEMA MULTIFORME MAJOR
- •CONNECTIVE TISSUE DISORDERS
- •PSEUDOXANTHOMA ELASTICUM
- •RELAPSING POLYCHONDRITIS
- •UVEITIS ASSOCIATED WITH JUVENILE IDIOPATHIC ARTHRITIS
- •WEGENER GRANULOMATOSIS
- •WEILL–MARCHESANI SYNDROME
- •SKELETAL DISORDERS
- •PHAKOMATOSES
- •NEUROFIBROMATOSIS TYPE 1
- •STURGE–WEBER SYNDROME
- •NEUROLOGIC DISORDERS
- •ACQUIRED INFLAMMATORY DEMYELINATING NEUROPATHIES
- •CREUTZFELDT–JAKOB DISEASE
- •NEOPLASMS
- •JUVENILE XANTHOGRANULOMA
- •LEIOMYOMA
- •ORBITAL RHABDOMYOSARCOMA
- •SEBACEOUS GLAND CARCINOMA
- •SQUAMOUS CELL CARCINOMA
- •MANAGEMENT OF SCLERAL RUPTURES 871.4 AND LACERATIONS 871.2
- •IRIS LACERATIONS 364.74, IRIS HOLES 364.74, AND IRIDODIALYSIS 369.76
- •ORBITAL IMPLANT EXTRUSION
- •SHAKEN BABY SYNDROME
- •PAPILLORENAL SYNDROME
- •ANTERIOR CHAMBER
- •CHOROID
- •ANGIOID STREAKS
- •CHOROIDAL DETACHMENT
- •SYMPATHETIC OPHTHALMIA
- •CONJUNCTIVA
- •ALLERGIC CONJUNCTIVITIS
- •BACTERIAL CONJUNCTIVITIS
- •LIGNEOUS CONJUNCTIVITIS
- •OPHTHALMIA NEONATORUM
- •CORNEA
- •BACTERIAL CORNEAL ULCERS
- •CORNEAL MUCOUS PLAQUES
- •CORNEAL NEOVASCULARIZATION
- •FUCHS’ CORNEAL DYSTROPHY
- •KERATOCONJUNCTIVITIS SICCA AND SJÖGREN’S SYNDROME
- •LATTICE CORNEAL DYSTROPHY
- •NEUROPARALYTIC KERATITIS
- •PELLUCID MARGINAL DEGENERATION
- •EXTRAOCULAR MUSCLES
- •ACCOMMODATIVE ESOTROPIA
- •CONVERGENCE INSUFFICIENCY
- •MONOFIXATION SYNDROME
- •NYSTAGMUS
- •EYELIDS
- •BLEPHAROCHALASIS
- •BLEPHAROCONJUNCTIVITIS
- •EPICANTHUS
- •FACIAL MOVEMENT DISORDERS
- •FLOPPY EYELID SYNDROME
- •MARCUS GUNN SYNDROME
- •SEBORRHEIC BLEPHARITIS
- •XANTHELASMA
- •GLOBE
- •BACTERIAL ENDOPHTHALMITIS
- •FUNGAL ENDOPHTHALMITIS
- •INTRAOCULAR PRESSURE
- •ANGLE RECESSION GLAUCOMA
- •GLAUCOMA ASSOCIATED WITH ELEVATED VENOUS PRESSURE
- •GLAUCOMATOCYCLITIC CRISIS
- •NORMAL-TENSION GLAUCOMA (LOW-TENSION GLAUCOMA)
- •IRIS AND CILIARY BODY
- •ACCOMMODATIVE SPASM
- •LACRIMAL SYSTEM
- •LACRIMAL HYPOSECRETION
- •DISLOCATION OF THE LENS
- •LENTICONUS AND LENTIGLOBUS
- •MICROSPHEROPHAKIA
- •MACULA
- •CYSTOID MACULAR EDEMA
- •EPIMACULAR PROLIFERATION
- •OPTIC NERVE
- •ISCHEMIC OPTIC NEUROPATHIES
- •TRAUMATIC OPTIC NEUROPATHY
- •ORBIT
- •EXTERNAL ORBITAL FRACTURES
- •INTERNAL ORBITAL FRACTURES
- •OPTIC FORAMEN FRACTURES
- •RETINA
- •ACQUIRED RETINOSCHISIS
- •ACUTE RETINAL NECROSIS
- •DIFFUSE UNILATERAL SUBACUTE NEURORETINITIS
- •RETINOPATHY OF PREMATURITY
- •SCLERA
- •SCLEROMALACIA PERFORANS
- •VITREOUS
- •VITREOUS WICK SYNDROME
- •Index
If the normal lid segments connect with too much tension, a lateral canthotomy and cantholysis with or without a semicircular temporal flap may be needed. This is especially important in the upper eyelid, where a tight eyelid can cause ptosis. Also, it is possible to attach a segment of the lid with normal cilia to the lid segment that has a few absent cilia. Doing so decreases the area of madarosis, and a small area of absent lashes is usually acceptable. The lateral canthotomy and cantholysis and semicircular flap will leave the temporal lid segment without lashes. This also is more cosmetically acceptable than absent central lashes.
Transplantation of hairs from the eyebrow to the eyelid is another treatment of madarosis. An incision is made at the junction of the skin-lid margin over the absent lash area. The direction of the brow hairs is studied, and the hairs pointing in the desired direction are chosen. A portion of the eyebrow that is equivalent in length and width to the lid with absent cilia and consisting of four rows of hairs is excised from the eyebrow. The correct depth of the graft is critical; it must include the hair follicles while avoiding too much subcutaneous tissue. The graft is sutured to surrounding skin and lid margin so the hairs are pointing away from the cornea and correspond to the direction of the adjacent normal cilia. Usually, the outer two rows of hairs eventually slough off. This procedure commonly leads to the loss of hairs over parts of the graft and usually unsatisfactory cosmetic results.
Another alternative to lash transplantation is the removal of a segment of the normal temporal lashes and placement of them, as described, into the area of madarosis. Naugle advocated this approach and claims good results. Again, the loss of temporal lashes to create central lashes is a cosmetically desirable tradeoff. Good results have also been achieved with the placement of individual lash grafts into areas of madarosis.
Blepharopigmentation is a technique in which pigment is tattooed into the eyelids. It is chiefly advocated to simulate eyeliner or to enhance the eyelashes. However, it can also be used to simulate eyelashes and is especially effective if the eyelashes are sparse rather than totally absent. Equipment and pigment are available through Dioptics (Irvine, CA) and Alcon Surgical (Irvine, CA). Pigment is applied beneath the skin in the desired density with a rapidly pulsating needle that is covered with pigment.
COMPLICATIONS
The transplantation of eyebrow hairs into the eyelid must not be considered a cure for madarosis. The relatively high incidence of postoperative loss of transplanted brow hairs and the frequently conspicuous appearance of the brow hairs that remain should alert the surgeon to surgical failure. Blepharopigmentation initially was a popular technique but presently is used only occasionally. One of the main problems has been the difficulty of removing pigment in patients who do not like the density or the areas to which it was applied.
REFERENCES
Levine M: Blepharopigmentation. In: Putterman A, ed: Cosmetic oculoplastic surgery. 2nd edn. Philadelphia, WB Saunders, 1993:324–333.
Naugle T: Cited by Caldwell D: Eyelash loss corrected by ciliary transplantation. Ophthalmol Times 7:52–53, 1982.
Putterman AM: Basic oculoplastic surgery. In: Peyman GA, Sanders DR, Goldberg MF, eds: Principles and practice of ophthalmology. Philadelphia, WB Saunders, 1980:2292–2295.
Putterman AM: Simplified reconstruction of the eyelids. In: Tandy ME, Jr, ed: Head and neck surgery. Face, nose and facial skull, part 1. Thierre, ER Kastenbauer, 1995:1:228–237.
Putterman AM, Migliori ME: Elective excision of permanent eyeliner. Arch Ophthalmol 106:1034, 1988.
248 MARCUS GUNN SYNDROME
742.8
Roger A. Dailey, MD
Portland, Oregon
John D. Ng, MD, MS, FACS
Portland, Oregon
ETIOLOGY/INCIDENCE
The jaw-winking syndrome, described by Marcus Gunn in 1883, is one type of congenital ptosis of a synkinetic nature that classically consists of ptosis of the upper eyelid associated with involuntary retraction of the lid during contraction of the ipsilateral pterygoid muscle. This syndrome accounts for 4% to 6% of all cases of congenital ptosis.
●The condition is usually sporadic, but familial cases have been reported.
●It is almost always unilateral and more severe in downgaze.
●The often-bizarre manifestations of this syndrome are due to a congenital misdirection of part of the fifth cranial nerve that aberrantly supplies the levator muscle; therefore, stimulation to the jaw sends impulses to the variably innervated levator.
●Electromyographic studies demonstrate a synkinetic relationship between the external pterygoid muscle and the levator muscle. The lid elevates with the jaw thrusting to the opposite side (ipsilateral external pterygoid) or with the jaw projecting forward or mouth opening (bilateral external pterygoid).
●A less common type is the internal pterygoid levator synkinetic group in which the lid elevates with the muscle closing or teeth clenching. The ptosis, as well as the retraction (‘winking’), varies in severity from minimal to cosmetically unacceptable, and either component may dominate the clinical picture.
SUMMARY |
|
COURSE/PROGNOSIS |
Madarosis (loss of eyelashes) has systemic, local, hysteric, trau- |
The Marcus Gunn syndrome is persistent throughout life, |
|
matic, and surgical causes. The first three categories can be |
although it is may become less conspicuous with time as |
|
treated medically. Makeup, horizontal lid shortening, and brow |
patients learn to control or mask its features. Surgical correc- |
|
and lid grafts can be used to treat traumatic and surgical |
tion can provide significant improvement in the ptosis, but |
|
causes. |
the synkinetic movement persists unless the levator muscle is |
|
Syndrome Gunn Marcus • 248 CHAPTER
453
Eyelids • 21 SECTION
completely removed from the lid and attached to the superior orbital rim at the arcus marginalis or extirpated.
DIAGNOSIS
●The initial presentation typically occurs soon after birth, when the infant begins to nurse. The ptotic lid is noted to rhythmically jerk upward.
●The retraction is most commonly demonstrated by opening and closing the mouth or by moving the jaw from side to side.
●It is rarely demonstrated by coughing, smiling, the Valsalva maneuver, swallowing, inspiration, or contraction of the platysma muscle.
●Several series have reported significant associations with other ocular problems, including strabismus, anisometropia, amblyopia, and Duane’s syndrome. The frequency of strabismus has been reported to be as high as 58% and includes superior rectus palsies, double elevator palsies, and horizontal deviations. Trigeminal-Abducens synkinesis has been reported.
TREATMENT
If amblyopia is present, it must be treated vigorously, and anisometropia must be corrected if it is significant.
Because the patient with Marcus Gunn syndrome brings to the clinician two separate problems (ptosis and jaw winking), the satisfactory elimination of both often is a challenging endeavor. In the evaluation of a patient, one must decide which component is more cosmetically intolerable-only then can the surgical plan be tailored accordingly and the best results obtained. A discussion with the patient or parents is important to ensure that they have realistic expectations and are aware that a compromise may be necessary.
In patients with very mild ptosis (less than 2 mm) and mild jaw wink (3 to 4 mm), one can perform a Müller’s muscle conjunctival resection as described by Putterman or a levator resection; even no treatment may be acceptable. If the ptosis is moderate and the jaw winking is minimal, a levator resection is the treatment of choice. Undercorrection of the ptosis has been a complication of this approach, and it is recommended that the resection be greater (4 to 5 mm more) than in the usual case of congenital ptosis. More predictable elevation may be achieved with a combined levator resection, Muellerectomy and conjunctivotarsectomy from an anterior approach. Unfortunately, an exacerbation of the jaw wink may occur because this procedure strengthens the levator muscle and the eyelid excursion then begins at a higher level.
When the jaw-winking component is severe, a levator resection exacerbates the wink. In this case, the jaw wink must be obliterated through release of the levator aponeurosis followed by a frontalis suspension. Dryden and coworkers described a reversible technique of suturing the levator aponeurosis to the arcus marginalis of the upper orbital rim to ensure its deactivation. Bilateral levator release with fascia lata suspension of both eyelids is the procedure of choice because the often-marked asymmetry of unilateral surgery is avoided. Bilateral frontalis suspension combined with only unilateral levator excision of the affected eye also is advocated (‘chicken-beard’ operation). If the patient or parents refuse bilateral surgery, the frontalis suspension may be performed on the affected eye with or without prior levator release.
To effect a levator release, a skin crease incision is made, and a small amount of preseptal orbicularis is resected. The underlying septum is identified, and nearly its entire length is incised horizontally. This allows identification of the levator aponeurosis, which is released from the tarsus and attached to the arcus marginalis with multiple 5-0 Dacron sutures. Care should be taken to avoid the supraorbital neurovascular bundle. A frontalis sling of the surgeon’s choice can then be performed. A double rhomboid as described by Beard is an excellent choice in this setting.
In cases in which the wink is not prominent and the levator does not have to be released, a transconjunctival frontalis suspension is an excellent option. Before the age of 3, the use of a synthetic sling is suggested, such as silicone rods or tubing. Banked fascia can be used, but in the authors’ experience, this material has not been satisfactory. After the age of 3, the child’s fascia lata has developed sufficiently to enable harvesting from either the midthigh or the hip area.
A stab incision is made at the upper edge of the brow where elevation of the eyelid by the surgeon’s finger gives the most pleasing cosmetic appearance. This incision need not be carried down to the periosteum. A small amount of skin undermining will ensure good closure over the fascia or silicone knot later. The eyelid is then everted over a Desmarres retractor and held in place with a forceps. A fascia lata strip measuring approximately 3 mm in width and 12 to 15 cm in length is loaded on a half-circle, reverse-cutting needle (Richard Allen no. 2164-4) and passed horizontally through the lid just anterior to the superior tarsal border. This horizontal limb should measure approximately 6 to 10 mm depending on the patient’s size. An attempt is made to incorporate the tarsal plate. The needle is then placed back in the lid, where it has just exited, and driven in a slightly posterior direction to an area immediately behind the superior orbital rim, ‘walked’ anteriorly over the rim, and brought out through the brow incision. Before this vertical fascia limb is pulled through, a small piece of 4-0 silk is placed as a marker suture at the junction of the horizontal and vertical limbs to facilitate removal of the vertical portion should repositioning of the fascia be necessary. The needle is reloaded with the opposite end of the fascia, brought through the entry site of the horizontal limb, and then directed superiorly to the brow incision in the same fashion. The result is a triangle-shaped sling with its base at the anterosuperior tarsal margin. The two vertical limbs can now be elevated to check lid margin height, contour, and symmetry. Any adjustments are made, and then the fascia is secured in the frontalis with a square knot. A 5-0 Dacron is sewn through the knot to ensure it will not slip. At this point, a good lid crease should be present, and the lid margin should be 1 to 2 mm above the desired postoperative level and in apposition with the globe.
Several modifications of the frontalis suspension have been advocated. The author favors the transconjunctival suspension in cases in which the levator has not been released. The advantages of this approach include a lesser chance of infection because it avoids low anterior skin incisions near the lash line, avoidance of visible traction lines below the skin, and facilitation of crease formation because the fascia is placed posteriorly to the orbital septum. In addition, normal attachments of the levator to the tarsus and skin are preserved so that when the frontalis muscle elevates the brow, the lid is indirectly raised and normal lid margin contour and apposition to the globe are maintained. This procedure is also inherently safer because the needle used to pass the fascia lata is never directed toward the eyeball, therefore minimizing the chance of ocular penetration.
454
In cases of unilateral ptosis in which the levator is released, a promising technique involving the advancement of a flap of frontalis muscle to the superior tarsus has been successful. The long-term results have not been published, but it appears to be far more successful than the corrugator muscle transpositions used in the 1960s. When an anterior approach is performed, the sling material is sutured to the tarsal surface. The Richard Allen needle is used to pass the free ends in a post-septal plane and out the suprabrow incision in the same manner as the transconjunctival approach. Fixation sutures may be used to evert the eyelashes prior to skin closure to avoid lash ptosis that can occur with frontalis suspensions.
COMMENTS
The jaw-winking syndrome is one type of congenital ptosis of a synkinetic nature that classically consists of ptosis of the upper eyelid associated with involuntary retraction of the lid during contraction of the ipsilateral pterygoid muscle. In general, the wink tends to become less noticeable with age, so if it is minimal and the patient has more than 4 mm of levator function, a standard levator resection should be highly successful. In cases of poor levator function, a frontalis suspension of some type should be used; if the wink is severe, the levator should be released from the tarsus and tacked to the arcus marginalis, followed by frontalis suspension.
REFERENCES
Beyer-Machule CK, Johnson CC, Pratt SG, Smith BR: The Marcus Gunn phenomenon. Orbit 4:15, 1985.
Bullock JD: Marcus Gunn jaw-winking ptosis: classification and surgical management. J Pediatric Ophthalmol Strabismus 17:375, 1980.
Dailey RA, Wilson DJ, Wobig JL: Transconjunctival frontalis suspension (TCFS). Ophthalmol Plast Reconstr Surg 7, 1991.
Darcet TW, Crawford JS: The quantification, natural course, and surgical results in 57 eyes with Marcus Gunn (jaw-winking) syndrome. Am J Ophthalmol 92:702–707, 1981.
Dryden RM, Fleuringer JL, Quickert MH: Levator transposition and frontalis sling procedure in severe unilateral ptosis and paradoxically innervated levator. Arch Ophthalmol 100:462, 1982.
Kodsi S: Marcus Gunn jaw winking with trigemino-abducens synkinesis. J AAPOS 4:316–7, 2000.
249 MELANOCYTIC LESIONS OF
THE EYELIDS 172.1
(Ephelis, Lentigo, Nevocellular Nevus,
Dermal Melanocytosis, Malignant
Melanoma)
Steven A. McCormick, MD, FACP
New York, New York
Tatyana Milman, MD, FAAO
New York, New York
ETIOLOGY
Benign melanocytic lesions of the eyelids are a diverse group of congenital and acquired lesions derived from neural crest mela-
nocytes. Three distinct cells of origin-epidermal melanocytes, nevocellular nevus cells, and dermal melanocytes-result in a variety of clinically distinct pigmented lesions of the skin. Classification schemes should distinguish among these three cell types and the location of origin. All of these cells have the capacity to synthesize and excrete melanin, the primary cutaneous pigment.
CLINICAL DIAGNOSIS
Examination should be performed in good light; the wide beam of the slit lamp is ideal. Size, location, and description of the lesion (height, surface and border characteristics, color, and so on) should be carefully recorded. The goal of the examination is to determine whether the lesion is likely to be a benign or malignant melanocytic lesion or another pigmented lesion of nonmelanocytic origin, such as seborrheic keratosis or pigmented basal or squamous cell carcinoma. Photographs of suspicious lesions are helpful in documenting the growth or changes in coloration that may signal malignancy.
The clinicopathologic features of these entities are discussed to assist the examiner in establishing the correct clinical diagnosis and in affecting appropriate management.
BENIGN LESIONS
Benign lesions derived from the epidermal melanocytes include the ephelis (common freckle), lentigo simplex, and solar lentigo (‘age spot’). All commonly affect the periocular skin, as well as skin elsewhere. Ephelides are not truly tumors, but are perhaps the most common of all skin lesions, affecting all whites to some degree, as well as pigmented races. Solar lentigines are also common in whites with excessive sun exposure.
Benign tumors composed of nevocellular nevus cells are referred to as melanocytic nevi (clinically, the simple term nevus is usually applied). Nevi are classified as junctional, intradermal, or compound based on the histologic location of the nevocellular proliferation. Most of the brown to black coloration results from melanin in the superficial skin, whereas tumefaction results from a dermal component. Location in the basal epidermis (junctional component) usually imparts a darker color (black to brown) than when the proliferation is limited to the dermis (intradermal nevus). When nevus cells are present in both locations, the term compound nevus is applied. Common nevi tend to evolve throughout life, beginning usually as pigmented macules or papules, increasing in height and/or pigmentation (especially under the hormonal influences of puberty or pregnancy), and finally regressing with depigmentation, fat infiltration, and fibrosis. Some larger nevi may harbor hair follicles or have a papillomatous surface.
Most nevi are noted at birth or in early childhood, and it is often difficult to determine whether a given lesion is congenital or acquired. Unlike ‘typical’ nevi, large congenital nevi (1 cm or more in diameter and evident at birth) are treated aggressively because of their propensity to give rise to malignant melanoma in approximately 12% of the cases. An example of congenital nevus affecting the eyelids is the ‘kissing’ nevus, which develops in utero before the normal development of the eyelid fissure. The nevus, thus, is located on apposed areas of the upper and lower eyelids. These, like other bulky nevi, are usually removed for cosmetic or mechanical reasons.
Eyelids249the ofCHAPTERLesions Melanocytic •
455
Eyelids • 21 SECTION
Another special variant is the Spitz nevus, or spindle and epithelioid cell nevus. This tumor commonly presents on the face of children and young adults as a small, sharply demarcated, symmetrical, dome-shaped papule, seated in the dermis. It may be erythematous and hyperpigmented, and may enlarge rapidly (up to 10 mm), mimicking malignant melanoma. Despite its aggressive histologic appearance, this lesion is benign and self-limited.
A controversial category is the dysplastic nevus, occurring in as many as 8% of the population. These nevi are macules that are usually larger than typical nevi (more than 4 mm) and present with less distinct borders and mottled pigmentation. Some have been compared morphologically to a ‘fried egg.’ Dysplastic nevi may occur in two clinical settings: in patients with a familial autosomal dominant dysplastic nevus syndrome (B-K mole syndrome), and as a sporadic condition (sporadic dysplastic nevus syndrome). In B-K mole syndrome the lifetime risk for the development of malignant melanoma approaches 100%. The lifetime risk for malignant transformation in a sporadic dysplastic nevus syndrome has been estimated between 18–20%, but the majority of experts believe that most sporadic dysplastic nevi will never transform into melanoma, and do not qualify them as precancerous lesions. The histologic parameters for these lesions are likewise debated. Caution suggests close observation and excision if change or growth is documented.
Benign lesions derived from dermal melanocytes include the blue nevus and nevus of Ota. The blue nevus results from a focal proliferation of dermal melanocytes in the deeper layers of the dermis. Pigment thus situated results in slate-gray to blue coloration through the Tyndall phenomenon. The nevus of Ota is a larger area of similar skin coloration that results from a less dense distribution of dermal melanocytes (dermal melanocytosis). Ipsilateral ocular melanocytosis usually is also present, imparting slate-gray pigmentation of the sclera and increased pigmentation in the uveal tract. These patients have no increased risk for the development of cutaneous malignant melanoma, but there is a reported increased risk of uveal, orbital, and CNS malignant melanoma; therefore, regular ophthalmic examinations should be performed.
Lesions of epidermal melanocytes
Ephelis (common freckle)
●Etiology: threshold dose of UV exposure leading to the development in genetically predisposed individuals; freckles darkening with additional sun exposure; no increase in melanocytes (only increased melanin production).
Solar lentigo
●Etiology: accumulative UV exposure leading to the development on sun-exposed skin of older individuals (hence the previous term ‘senile lentigo’).
●Clinical findings: multiple large, evenly pigmented macules on sun-exposed skin (1 to 7 mm); may gradually enlarge and coalesce; in xeroderma pigmentosum, often appear by adolescence; histologically, no obvious (or minimal) increase in the number of epidermal melanocytes (increased melanin production).
●Treatment: both UV protection and avoidance of sun exposure.
Melanocytic (nevocellular) nevi
●Etiology: hamartia of melanoblasts arrested in their normal migration and development into epidermal melanocytes; ubiquitous and affect all races; sun exposure and hormonal factors may be operative (often enlarge at puberty and in pregnancy).
●Clinical findings: morphology and pigmentation vary from small, flat macules to elevated, dome-shaped lesions; may be pedunculated and papillomatous; pigmentation ranges from tan to black; usually evenly pigmented; may increase in size over time.
●Classification: junctional, intradermal, or compound types (histologically); dysplastic nevus is a controversial subtype that may possibly be a precursor for melanoma; other special types includes Spitz nevus, balloon cell nevus, and congenital melanocytic nevus.
●Treatment: excisional biopsy, if indicated, or observation.
Lesions of dermal melanocytes
●Etiology: increased numbers of dermal melanocytes, forming focal tumors (blue nevi) or diffuse distribution of melanocytes (nevus of Ota).
●Clinical findings: blue nevi with slate-gray to blue pigmentation due to the deep-seated pigmentation (Tyndall’s phenomenon); common in head and neck region; may be slightly raised, but epidermis not affected; nevus of Ota not usually elevated, but displays diffuse slate-gray pigmentation in distribution of the trigeminal nerve; may be bilateral; ipsilateral scleral pigmentation usually present; increased risk of uveal, orbital, CNS melanoma.
●Treatment: excisional biopsy of blue nevus if tumefaction is large or cosmetically undesirable; no practical treatment available for nevus of Ota.
●Clinical findings: small tan to brown macules on sun- MALIGNANT AND PREMALIGNANT LESIONS exposed skin (less than 1 to 3 mm).
●Treatment: no treatment.
Lentigo simplex
●Etiology: no predilection for sun-exposed skin; no darkening of the lesions with UV exposure; multiple lesions suggesting an association with systemic syndromes (e.g. Peutz–Jeghers, LAMB, or leopard syndromes); histologically, increase in number of epidermal melanocytes; regarded by some as a form of evolving melanocytic nevus.
●Clinical findings: small brown to black macules, darker and larger than ephelis; clinically indistinguishable from a junctional nevus
●Treatment: no treatment
Primary malignant melanoma of the eyelid and periocular skin is relatively rare, representing 1% to 5% of all eyelid malignancies. The incidence of cutaneous melanoma has been increasing at an alarming rate (more than 600% increase from 1950 to 2000), and undoubtedly so will the incidence of eyelid melanoma. Most melanomas arise de novo from transformed, atypical basal melanocytes, but in 25% to 35% of cases, histologic remnants of a benign nevus may be detected. The clinician must be suspicious of the ‘changing mole’ or any newly recognized pigmented lesion. The practitioner’s task is to recognize the surface characteristics that are harbingers of malignancy. Malignant lesions tend to display irregular or notched borders rather than the smooth, symmetric borders of nevi and other pigmented lesions. They often display variegated pigmentation,
456
ranging from pink/red to brown/black, whereas nevi tend to be uniformly pigmented. Acquired nevi tend to be less than 5 mm in diameter; malignant lesions are usually larger. However, other pigmented, nonmelanocytic lesions (e.g. seborrheic keratosis and keratoacanthoma) may be large. Change in clinical appearance and symptoms (i.e. evolution) of the lesion are uncommon in nevi, but are frequently observed in cutaneous malignant melanoma. The ‘ABCDE rule’ of clinical signs is a helpful mnemonic: asymmetry, border irregularity, variation in color, diameter of more than 5 mm, and evolution.
Lentigo maligna (Hutchinson’s freckle) may be considered a premalignant lesion that has a natural history unlike the other types of malignant melanoma. It is a relatively common finding on the face in elderly Caucasian individuals, and often involves the lower eyelid and lateral canthal region. Lentigo maligna begins as one or more pigmented patches with irregular borders, and enlarges slowly (over several years). As the lesion expands, the pigmentation may change as some areas regress and others proliferate. Lentigo maligna may, after this protracted in situ phase, progress to lentigo malignant melanoma, probably the most common melanoma type affecting the eyelid skin. The appearance of nodularity within the lesion is often an indicator of progression to the invasive stage. The risk of progression appears to be low (variable lifetime risk figures are quoted: from 5% to 50%).
Malignant melanoma of the periocular skin, arising de novo or within a pre-existing acquired or congenital nevus, is classified as either superficial spreading melanoma or nodular melanoma. Superficial spreading melanoma, the most common melanoma subtype of the head and neck region, begins as a brown to gray or rose-colored, minimally elevated in situ lesion with irregular, notched borders. Unlike with lentigo maligna, the lesion is rarely more than a few centimeters in its radial growth phase and becomes minimally invasive much earlier (typically within 1 year). It is important to recognize and excise the lesion at this stage. Induration, elevation, and mottling are early signs of invasion.
Nodular malignant melanoma begins as an elevated, often darkly pigmented tumor that increases in bulk rapidly and, unlike superficial spreading melanoma, often ulcerates and bleeds. A radial growth phase is not usually recognized; an in situ lesion is not included in the classification. Because the vertical invasion occurs early, nodular melanoma usually presents with a smaller diameter than superficial spreading melanoma (often less than 1 cm). As a result of its early and aggressive invasive growth, this type of cutaneous melanoma carries the worst prognosis.
Staging schemes separate patients with local disease only (stages I and II), with local nodal metastases (stage III), or with distant nodal or visceral metastases (stage IV). Approximately 80–90% of cases are diagnosed in stages I and II, with a 5-year survival rate of around 90%. Prognosis in localized disease is gauged on the depth of invasion as measured microscopically. Breslow found that tumors of less than 0.76 mm in thickness (measured from the granular cell layer of the epidermis to the deepest extent of invasion) did not metastasize (and therefore did not require regional node dissection). In patients with tumors of more than 1.5 mm, survival rates are doubled if regional lymphadenectomy is performed. Sentinel lymph node biopsy is currently recommended for localized lesions with tumor thickness greater than 1 mm; if positive, the biopsy is followed by regional lymph node dissection. Prognosis is poor for stages III and IV; 5-year survival rates are reported as 60% for regional (stage III) disease, and 14% for distal metastatic
disease. In regional disease, the number of involved lymph nodes, tumor burden within the lymph nodes, and ulceration within the primary tumor are important predictors of survival.
Lentigo maligna and lentigo maligna melanomas
●Etiology: may occur as a result of chronic, cumulative sun exposure; atypical melanocytes proliferate in the basal regions of the epidermis in Hutchinson’s freckle; invasion in 5%–50% (lenitgo maligna melanoma), but usually only after many years of evolution.
●Clinical findings: slowly enlarging irregular pigmented macule or macules with irregular borders that evolve over several years; frequently involve the lateral canthal region and lower eyelid; induration, elevation, and change in coloration possible signs of invasion.
●Treatment: excision, especially if nodularity develops within the macule.
Malignant melanoma (superficial spreading or nodular)
●Etiology: may be caused by episodic, intense sun exposure; malignant transformation of basal epidermal melanocytes (or less commonly, malignant degeneration of nevus cells); growth proceeds from an in situ phase (recognized in superficial spreading melanoma) to invasive growth, which proceeds more rapidly in nodular melanoma.
●Clinical findings: the ABCDE rule (asymmetry, border irregularity, variation in color, diameter of more than 5 mm, evolution) is useful; pigmented macules with these features should be considered suspicious for superficial spreading melanoma; nodular melanomas present as enlarging, elevated lesions with variable dark pigmentation; evolution may be noted in up to 80%; induration and changing pigmentation are harbingers of malignancy.
●Treatment: excisional biopsy of suspicious lesions, preferably with up to 1-cm margins of resection; incisional biopsy of large lesions if the diagnosis is in question; sentinel lymph node biopsy for lesions with tumor thickness greater than 1 mm; regional lymph node dissection if positive nodes are identified.
SUMMARY
Pigmented lesions of the eyelid and periocular skin present a challenge to the ophthalmologist, but the importance of recognizing suspicious tumors cannot be overemphasized. Lesions removed early in their course carry an extremely favorable prognosis, and surgical extirpation in the facial region is accomplished with limited cosmetic effects when lesions are small. The task of the clinician is to differentiate among benign, premalignant, and malignant lesions with the use of clinical examination and review of the patient’s historical observations of the lesion. The clinician must also recognize that several nonmelanocytic lesions may present as pigmented tumors; these include pigmented basal cell carcinoma, actinic keratosis, keratoacanthoma, seborrheic keratosis, and dermatofibroma. Suspicious lesions should be biopsied.
REFERENCES
Abbasi NR, Shaw HM, Rigel DS, et al: Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 292(22):2771–2776, 2004.
Eyelids the of Lesions Melanocytic • 249 CHAPTER
457
Eyelids • 21 SECTION
Balmaceda CM, Fetell MR, O’Brien JL, et al: Nevus of Ota and leptomeningeal melanocytic lesions. Neurology 43(2):381–386, 1993.
Clark WH, Elder DE, Guerry D, et al: A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15:1147–1165, 1984.
Cramer SF: The histogenesis of acquired melanocytic nevi. Based on a new concept of melanocytic differentiation. Am J Dermatopathol 6 Suppl: 289–298, 1984.
Cramer SF: The origin of epidermal melanocytes: implications for the histogenesis of nevi and melanomas. Arch Pathol Lab Med 115:115–119, 1991.
Crowson AN, Magro CM, Sanchez-Carpintero I, et al: The precursors of malignant melanoma. Recent Results Cancer Res160:75–84, 2002.
Elder DE, Murphy GF: Atlas of tumor pathology: melanocytic tumors of the skin (third series, fascicle 2). Washington, DC, Armed Forces Institute of Pathology, 1991.
Grossniklaus HE, McLean IW: Cutaneous melanoma of the eyelid: clinicopathologic features. Ophthalmology 98:1867–1873, 1991.
Kienstra MA, Padhya TA: Head and neck melanoma. Cancer Control 12(4):242–247, 2005.
Le AD, Fenske NA, Glass LF, et al: Malignant melanoma: differential diagnosis of pigmented lesions. J Fla Med Assoc 84(3):166–174, 1997.
Lever WF, Schaumberg-Lever G: Histopathology of the skin. Philadelphia, JB Lippincott, 1990, pp. 756–805.
Lopransi S, Mihm MC: Clinical and pathological correlation of malignant melanoma. J Cutan Pathol 6:180–194, 1979.
Rager EL, Bridgeford EP, Ollila DW: Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment. Am Fam Physician 72(2):269–276, 2005.
Spencer WH (ed): Ophthalmic pathology: an atlas and text. Philadelphia, WB Saunders, 1996:2261–2278.
Stevenson O, Ahmed I: Lentigo maligna : prognosis and treatment options. Am J Clin Dermatol 6(3):151–164, 2005.
Vaziri M, Buffam FV, Martinka M, et al: Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology 109(5):901– 908, 2002.
250 ORBITAL FAT HERNIATION 374.34
(Eyelid Fat Prolapse, Orbital Fat
Prolapse, Adipose Palpebral Bags,
Baggy Eyelids)
Eric A. Steele, MD
Portland, Oregon
Roger A. Dailey, MD
Portland, Oregon
ETIOLOGY
Fullness of either the upper or lower eyelid can result from the herniation of orbital fat through the orbital septum, fluid retention or accumulation in the periocular tissues, prolapse of the lacrimal gland, or excess skin (dermatochalasis). Orbital fat herniation results from atrophy and dehiscence of the orbital septum allowing for forward prolapse of the orbital fat pads. In the upper eyelid, orbital fat prolapse may contribute to mechanical ptosis, as well as pose cosmetic concerns in conjunction with dermatochalasis. In the lower eyelid, fat prolapse will result in cosmetic deformity based on underlying bony anatomy and the status of other mid facial soft tissues.
●The thin nature of the orbital septum allows hereditary or involutional herniation of orbital fat.
●Thyroid immune-related orbitopathy may increase the volume of fat and lead to prolapse in the upper and lower eyelids.
●Posterior sub-Tenon injection of triamcinolone may cause ptosis and/or orbital fat prolapse.
DIAGNOSIS
The diagnosis is made on the basis of careful general medical and ophthalmologic history and clinical examination. An examination of eyelid fullness is made by palpation and ballottement of the globe with observation of the fat pads.
Differential diagnosis
●Dermatochalasis.
●Prolapsed lacrimal gland.
●Eyelid edema or blepharochalasis.
●Thyroid immune related orbitopathy.
●Festoons or cheek bags.
All of the above may be present in conjunction with orbital fat prolapse.
TREATMENT
Local
●Make-up applied by a skilled aesthetician may slightly improve the cosmetic appearance.
Surgical
Upper eyelid
●Surgical intervention in the upper eyelid will often involve simultaneous treatment of dermatochalasis.
●Surgery is performed most commonly with the patient under local or monitored anesthesia. After infiltration with a local anesthetic agent containing epinephrine, the amount of skin to be excised is marked. The lower border of skin excision coincides with the eyelid crease.
●Incision through skin and muscle is made with a scalpel or CO2 laser. Skin and muscle are excised either in one flap or separately. The orbital septum is identified and incised in a complete horizontal ‘open sky’ fashion to expose the preaponeurotic fat pads.
●After supplemental injection of fat pads with anesthetic agent if necessary, the medial and central fat pads are excised as needed to obtain the desired result. Clamping of the fat pads can be used; meticulous hemostasis is mandatory.
●Care is taken to avoid resection of the lacrimal gland or overzealous resection of fat, especially in the medial central pad, to avoid an A-frame deformity or hollowed appearance after surgery.
●The skin edges are closed with a running nylon suture (6-0 or 7-0); the septum is not sutured. Crease formation stitches through the levator aponeurosis are used as desired.
Lower eyelid: transcutaneous
●The transcutaneous approach can be used where excessive skin (dermatochalasis) accompanies orbital fat herniation. Anesthesia is performed as described for the upper eyelid.
458
A subciliary incision is placed 2 to 3 mm below the lashes of the lower eyelid. Skin and muscle are incised with a scalpel or CO2 laser.
●The skin-orbicularis flap is then dissected inferiorly to expose the orbital septum.
●Stab incisions or wide incision of the septum is made over the prolapsing fat pads. The fat pads (medial, central, and temporal) are teased out of their capsules and excised as needed with any combination of clamping, cautery and CO2 laser. Meticulous hemostasis is used.
●Superior sulcus deformity (excessive fat removal);
●Ptosis;
●Lacrimal gland injury;
●Blindness (orbital hemorrhage).
COMMENTS
Orbital fat prolapse is primarily a cosmetic concern; thus, care for these patients should be undertaken with a thorough knowl-
●Options at this point include a release of the arcus margiedge of anatomy, patient expectations, and surgical technique.
nalis and draping of excess orbital fat over the orbital rim to improve contour deformities in the midface and the tear trough deformity. The redraped orbital fat can be fixed to the suborbicularis oculi fat pad or periosteum as desired with an absorbable suture.
●The septum is not closed, and the skin-orbicularis flap is draped back over the residual fat pads; then, skin, muscle, or both are excised as necessary. Care must be taken to have the patient look up and open the mouth to determine the safe amount of skin and muscle to be excised.
Lower eyelid: transconjunctival
●Transconjunctival lower eyelid blepharoplasty is the procedure of choice for most cases of pure orbital fat prolapse without significant dermatochalasis.
●After appropriate anesthesia, the globe is protected with a Jaeger lid plate using gentle pressure to prolapse the fat pads. The lower lid is pulled down by the assistant, and an incision is made through the conjunctiva and capsulopalpebral fascia to reach the orbital fat pads. The incision is placed approximately midway between the inferior border of the lower tarsus and the inferior fornix and can be made with scissors, scalpel, cutting cautery, radiofrequency, or CO2 laser.
●The tarsus is retracted inferiorly with a Desmarres retractor, and the capsulopalpebral fascia is retracted superiorly with a traction suture. The fat pads are identified and teased from their respective capsules. Care is taken to identify and avoid damage to the inferior oblique muscle between the central and medial fat pads. Fat is removed in a graded fashion to obtain the desired result.
State-of-the-art care includes the use of CO2 laser and attention to fat preservation and repositioning techniques.
REFERENCES
Baylis HI, Long JA, Groth MJ: Transconjunctival lower eyelid blepharoplasty: technique and complications. Ophthalmology 96:1027–1032, 1989.
Dailey RA, Wobig JL: Eyelid anatomy. J Dermatol Surg Oncol 18:1023–1027, 1992.
Del Canto AJ, Downs-Kelly E, Perry JD: Ptosis and orbital fat prolapse after posterior sub-Tenon’s capsule triamcinolone injection. Ophthalmology 112:1092–1097, 2005.
Hamra ST: Arcus marginalis release and orbital fat preservation in midface rejuvenation. Plast Reconst Surg 96:354–362, 1995.
Wobig JL, Dailey RA: Oculofacial plastic surgery. New York, Thieme, 2004.
251 PTOSIS 374.30
(Blepharoptosis)
Eric A. Steele, MD
Portland, Oregon
Roger A. Dailey, MD
Portland, Oregon
The term blepharoptosis refers to an abnormally low upper
●Options include release of the arcus marginalis and reposieyelid. The retractors of the upper lid are the levator palpebrae tioning of orbital fat across the orbital rim to correct midsuperioris, innervated by the superior division of the oculomo-
|
facial contour abnormalities or tear trough deformity. The |
|
tor nerve and responsible for the majority of lid elevation, and |
|
repositioned fat can be fixed with buried absorbable sutures |
|
the superior tarsal (Müller’s) muscle, a smooth, sympathetically |
|
or with externalized sutures removed in the postoperative |
|
innervated muscle responsible for approximately 1 to 2 mm of |
|
period. |
|
lid elevation. The protractor of the eyelids is the orbicularis |
● |
The conjunctival incision is not closed. |
|
oculi muscle, and lid position is determined by the balance of |
|
|
|
these forces. |
COMPLICATIONS |
|
ETIOLOGY |
|
|
|
|
|
Complications can result from an incomplete preoperative workup or poor surgical planning. Failure to recognize preexisting conditions such as lid laxity, lid edema, metabolic conditions (e.g. thyroid conditions, allergy, sodium imbalance), hypertrophy of orbicularis oculi, relative prominence of the globe, blepharochalasis, or lid malpositions will compromise the surgical result and patient satisfaction.
Complications include:
●Lower lid ectropion and/or retraction;
●Rounding of the lateral canthal angle;
●Upper eyelid retraction and lagophthalmos;
Ptosis has traditionally been categorized as congenital versus acquired. A mechanistic classification may be more useful in distinguishing types of ptosis and the appropriate surgical intervention. Accordingly, ptosis may be divided into myogenic, neurogenic, aponeurotic, or mechanical causes.
Myogenic ptosis
●Myogenic causes include any disorder with reduced or absent levator palpebrae muscle function secondary to maldevelopment, dystrophy, degeneration, or injury of the levator muscle.
251 CHAPTER Ptosis •
459
Eyelids • 21 SECTION
●Congenital ptosis is usually myogenic and thought to result from abnormal development of the levator muscle (fibrofatty replacement of the normal striated muscle fibers). It may be unilateral or bilateral and is generally characterized by reduced levator muscle function, lid lag on downgaze, poor or absent lid crease, and lagophthalmos (incomplete closure). Congenital ptosis may occasionally be inherited as an autosomal dominant trait, but it is usually an isolated congenital anomaly. Ptosis is associated with many syndromes, including the blepharophimosis syndrome (an autosomal dominant condition typified by bilateral ptosis, telecanthus, epicanthus inversus, and phimosis). In addition, congenital ptosis may be associated with superior rectus dysfunction, amblyopia, astigmatism, anisometropia, and strabismus. Amblyopia, when seen with ptosis, is usually secondary to induced astigmatism or anisometropia and only rarely results from sensory deprivation. Occlusion or other treatment modalities should be continued after ptosis repair.
●Other causes of myogenic ptosis include chronic progressive external ophthalmoplegia, congenital fibrosis syndrome, disorders of the neuromuscular junction (e.g. myasthenia gravis), and muscular dystrophies such as oculopharyngeal muscular dystrophy and myotonic dystrophy.
●Occasionally, trauma may primarily damage the levator muscle itself without affecting its aponeurosis or innervation.
Neurogenic ptosis
●Neurogenic causes of ptosis include cranial nerve III dysfunction (with partial or complete ptosis depending on the site and degree of nerve involvement), Horner’s syndrome (loss of sympathetic innervation to Müller’s muscle, typically resulting in 2 mm or less of ptosis), Marcus Gunn jaw-winking syndrome (unilateral ptosis with synkinesis of the ipsilateral pterygoid and levator muscles such that jaw movement may result in retraction of the ptotic lid), Guillain–Barré syndrome (especially the Miller–Fisher variant in which ptosis may occur in association with ophthalmoplegia, mydriasis, ataxia, and areflexia), botulism (characterized by dilated, sluggish pupils, dry mouth, flaccid paresis, and ptosis), multiple sclerosis, and ophthalmoplegic migraine. Of course, trauma with resultant sympathetic or cranial nerve III damage may also cause ptosis on a neurogenic basis.
DIAGNOSIS
Clinical signs and symptoms
●The evaluation of ptosis requires a careful history to determine the age of onset, familial incidence, rate of progression, variability/fatigability, and association with other ocular findings.
Laboratory findings
●As part of a complete ophthalmologic evaluation, motility assessment, pupillary testing, and inspection of Bell’s phenomenon should be performed.
●Palpebral fissure measurement (9 mm is considered normal), margin-reflex (from upper lid to the light reflex) distance measurement, and estimation of levator excursion while immobilizing the frontalis muscle (to evaluate levator palpebrae muscle function) will determine the type of surgical intervention best suited for the patient. It is also helpful to manually elevate the ptotic lid to eliminate the effect of Hering’s law and assess the amount of ptosis in the contralateral eye.
●Should any variability or fatigability be elicited, a Tensilon test and serologic evaluation for acetylcholine receptor antibodies may be helpful in diagnosing myasthenia gravis.
●In patients with mild ptosis (2 mm or less), testing with 2.5% phenylephrine eyedrops can help determine the expected result of ptosis repair via a conjunctiva-Müller’s resection (see below).
●Visual field testing with ptosis and then with manual elevation of the eyelid can be used to determine the degree of visual field loss associated with ptosis. Documentation of field loss and preoperative photographs are usually required by health insurance carriers before authorization for surgical repair.
Differential diagnosis
●True ptosis must be distinguished from pseudoptosis, in which an abnormally low upper eyelid is caused by factors other than dysfunction of the lid elevators. Conditions that mimic ptosis include vertical misalignment, as occurs in hypotropia, blepharospasm, or squinting, and contralateral lid retraction, as occurs in thyroid eye disease and dermatochalasis.
●The systemic conditions and congenital syndromes associated with ptosis should be sought, and the appropriate treatment should be instituted.
Aponeurogenic ptosis
●Aponeurotic or aponeurogenic ptosis is the most common cause of acquired ptosis. Stretching of the levator aponeurosis or dehiscence of its insertion onto the tarsal plate (as occurs with aging, trauma, or hard contact lens wear or after ocular surgery with a lid speculum) causes acquired ptosis, characterized by normal levator function, a high lid crease, deep supratarsal sulcus, and increased ptosis on downgaze.
Mechanical ptosis
●Mechanical causes of ptosis include cicatricial changes, lid masses, dermatochalasis, brow ptosis, and microphthalmos or enophthalmos. Floppy eyelid syndrome, characterized by lid laxity, chronic papillary conjunctivitis, and lash ptosis, may also present with ptosis.
TREATMENT
Surgical
●In the majority of patients with acquired ptosis, good levator function (8 mm or more) can be demonstrated, and the preferred method of repair is an external lid crease incision with reattachment or advancement of the levator aponeurosis to the tarsal plate. The lid crease should be carefully marked before infiltration of the eyelid with a local anesthetic agent. After a skin incision at the lid crease, the dissection is carried through the orbicularis muscle and orbital septum, exposing the preaponeurotic adipose tissue anterior to the levator aponeurosis. The aponeurosis is then separated from its attachments to the overlying adipose tissue and the underlying Müller’s muscle. The tarsal plate is exposed, and the aponeurosis is reattached to the tarsus
460
